Protection Against Malaria by Plasmodium yoelii Sporozoite Surface Protein 2 Linear Peptide Induction of CD4+ T Cell-and IFN-γ-Dependent Elimination of Infected Hepatocytes

Journal of Immunology

Volumn 157, Issue 9, 1996, Pages 4061-4067

  Wang, Ruobing ^a   Charoenvit, Yupin ^a   Corradin, Giampietro ^b   De La Vega, Patricia ^a   Franke, Eileen D ^a   Hoffman, Stephen L ^a  

^a NAVAL MEDICAL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; MALARIA VACCINE; PEPTIDE FRAGMENT; PROTOZOAL PROTEIN; RECOMBINANT VACCINE; SPOROZOITE SURFACE PROTEIN 2, PLASMODIUM YOELLI; SPOROZOITE-SURFACE PROTEIN 2, PLASMODIUM YOELLI;

A J MOUSE; ADOPTIVE TRANSFER; AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; C57BL MOUSE; CD4+ T LYMPHOCYTE; CYTOTOXIC T LYMPHOCYTE; FEMALE; IMMUNIZATION; IMMUNOLOGY; LIVER; LYMPHOCYTE DEPLETION; MALARIA; MOLECULAR GENETICS; MOUSE; PARASITOLOGY; PATHOLOGY; PHYSIOLOGY; PLASMODIUM YOELII; VACCINATION;

ADOPTIVE TRANSFER; AMINO ACID SEQUENCE; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; IMMUNIZATION; INTERFERON TYPE II; INTERLEUKIN-2; INTERLEUKIN-4; LIVER; LYMPHOCYTE DEPLETION; MALARIA; MALARIA VACCINES; MICE; MICE, INBRED A; MICE, INBRED BALB C; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PLASMODIUM YOELII; PROTOZOAN PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; VACCINATION; VACCINES, SYNTHETIC;

EID: 0030293622     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Charoenvit, Y., M. L. Leef, L. F. Yuan, M. Sedegah, and R. L. Beaudoin. 1987. Characterization of Plasmodium yoelii monoclonal antibodies directed against stage-specific sporozoite antigens. Infect. Immun. 55:604.
2. Hedstrom, R. C., J. R. Campbell, M. L. Leef, Y. Charoenvit, M. Carter, M. Sedegah, R. L. Beaudoin, and S. L. Hoffman. 1990. A malaria sporozoite surface antigen distinct from the circumsporozoite protein. Bull. World Health Organ. 68(Suppl.):152.
3. Rogers, W. O., M. D. Rogers, R. C. Hedstrom, and S. L. Hoffman. 1992 Characterization of the gene encoding sporozoite surface protein 2, a protective Plasmodium yoelii sporozoite antigen. Mol. Biochem. Parasitol. 53:45.
4. Khusmith, S., Y. Charoenvit, S. Kumar, M. Sedegah, R. L. Beaudoin, and S. L. Hoffman. 1991. Protection against malaria by vaccination with sporozoite surface protein 2 plus CS protein. Science 252:715.
5. + cytotoxic T cell clone recognizing sporozoite surface protein 2. Infect. Immun. 62:2979.
6. Rogers, W. O., A. Malik, S. Mellouk, K. Nakamura, M. D. Rogers, A. Szarfman, D. M. Gordon, A. K. Nussler, M. Aikawa, and S. L. Hoffman. 1992. Characterization of Plasmodium falciparum sporozoite surface protein 2. Proc. Natl. Acad. Sci. USA 89:9176.
7. Robson, K. J. H., J. R. S. Hall, M. W. Jennings, T. J. R. Harris, K. Marsh, C. I. Newbold, V. E. Tate, and D. J. Weatherall. 1988. A highly conserved amino-acid sequence in thrombospondin, properdin and in proteins from sporozoites and blood stages of a human malaria parasite. Nature 335:79.
8. Wizel, B., W. O. Rogers, R. A. Houghten, D. E. Lanar, J. A. Tine, and S. L. Hoffman. 1994. Induction of murine cytotoxic T lymphocytes against Plasmodium falciparum sporozoite surface protein 2. Eur. J. Immunol. 24:1487.
9. Wizel, B., R. Houghten, P. Church, J. A. Tine, D. E. Lanar, D. M. Gordon, and S. L. Hoffman. 1995. HLA-A2-restricted cytotoxic T lymphocyte responses to multiple Plasmodium falciparum sporozoites surface protein 2 epitopes in sporozoite-immunized immunized volunteers. J. Immunol. 155:766.
10. Aidoo, A., A. Lalvani, C. E. M. Allsopp, M. Plebanski, S. J. Meisner, P. Krausa, M. Browning, S. Morris-Jones, F. Gotch, D. A. Fidock, M. Takiguchi, K. J. H. Robson, B. M. Greenwood, P. Druilhe, H. C. Whittle, and A. V. S. Hill. 1995. Identification of conserved antigenic components for a cytotoxic T lymphocyte-inducing vaccine against malaria. Lancet 345:1003.
11. Hoffman, S. L., M. Sedegah, and A. Malik. 1994. Cytotoxic T lymphocytes in humans exposed to Plasmodium falciparum by immunization or natural exposure. Curr. Top. Microbiol. Immunol. 189:187.
12. + T cell clones against Plasmodium yoelii liver stages. J. Immunol. 150:1471.
13. + T lymphocytes from mice immunized with a synthetic malaria peptide. Proc. Natl. Acad. Sci. USA 88:7963.
14. + T cells from a sporozoite-immunized volunteer recognize the Plasmodium falciparum CS protein. Int. Immunol. 3:997.
15. Wang, R., Y. Charoenvit, G. Corradin, R. Porrozzi, R. L. Hunter, G. Glenn, C. R. Alving, P. Church, and S. L. Hoffman. 1995. Induction of protective polyclonal antibodies by immunization with a Plasmodium yoelii circumsporozoite protein multiple antigen peptide vaccine. J. Immunol. 154:2784.
16. Valmori, D., A. Pessi, E. Bianchi, and G. Corradin. 1992. Use of human universally antigenic tetanus toxin T cell epitopes as carriers for human vaccination. J. Immunol. Methods 149:717.
17. Valmori, D., J. F. Romero, Y. Men, J. L. Maryanski, P. Romero, and G. Corradin. 1994. Induction of a cytotoxic T cell response by co-injection of a T helper peptide and a cytotoxic T lymphocyte peptide in incomplete Freund's adjuvant (IFA): further enhancement by pre-injection of IFA alone. Eur. J. Immunol. 24: 1458.
18. Charoenvit, Y., W. E. Collins, T. R. Jones, P. Millet, L. Yuan, G. H. Campbell, R. L. Beaudoin, J. R. Broderson, and S. L. Hoffman. 1991. Inability of malaria vaccine to induce antibodies to a protective epitope within its sequence. Science 251:668.
19. + cells in immunity to malaria sporozoites. J. Immunol. 151:2690.
20. Sedegah, M., F. Finkelman, and S. L. Hoffman. 1994. Interleukin-12 induction of interferon gamma-dependent protection against malaria. Proc. Natl. Acad. Sci. USA 91:10700.
21. Grillot, D., M. Michel, I. Muller, C. Tougne, L. Renia, D. Mazier, G. Corradin, P. H. Lambert, J. A. Louis, and G. Del Giudice. 1990. Immune responses to defined epitopes of the circumsporozoite protein of the murine malaria parasite, Plasmodium yoelii. Eur. J. Immunol. 20:1215.
22. Mellouk, S., N. Berbiguier, P. Druilhe, M. Sedegah, B. Galey, L. Yuan, M. Leef, Y. Charoenvit, C. Paul, S. L. Hoffman, and R. Beaudoin. 1990. Evaluation of an in vitro assay aimed at measuring protective antibodies against sporozoites. Bull. World Health Organ. 68(Suppl.):52.
23. Weiss, W. R., S. Mellouk, R. A. Houghten, M. Sedegah, S. Kumar, M. F. Good, J. A. Berzofsky, L. H. Miller, and S. L. Hoffman. 1990. Cytotoxic T cells recognize a peptide from the circumsporozoite protein on malaria-infected hepatocytes. J. Exp. Med. 171:763.
24. Charoenvit, Y., S. Mellouk, C. Cole, R. Bechara, M. F. Leef, M. Sedegah, L. F. Yuan, F. A. Robey, R. L. Beaudoin, and S. L. Hoffman. 1991. Monoclonal, but not polyclonal antibodies protect against Plasmodium yoelii sporozoites. J. Immunol. 146:1020.
25. Sedegah, M., R. Hedstrom, P. Hobart, and S. L. Hoffman. 1994. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. Proc. Natl. Acad. Sci. USA 91:9866.
26. + T cell-, interferon-γ-, and nitric oxide-dependent immunity. J. Exp. Med. 183:1739.
27. Mellouk, S., S. J. Green, C. A. Nacy, and S. L. Hoffman. 1991. IFN-gamma inhibits development of Plasmodium berghei exoerythrocytic stages in hepatocytes by an L-arginine-dependent effector mechanism. J. Immunol. 146:3971.
28. Mellouk, S., S. L. Hoffman, Z. Liu, P. De La Vega, T. R. Billiar, and A. K. Nussler. 1994. Nitric oxide-mediated antiplasmodial activity in human and murine hepatocytes induced by gamma interferon and the parasite itself: enhancement by exogenous tetrahydrobiopterin. Infect. Immun. 62:4043.
29. + thymocytes selected by MHC class I molecules. Science 263:1774.
30. + cells in the liver of mice. J. Exp. Med. 180:699.
31. Bunschoten, H., B. Dietzschold, I. Claassen, R. Klapmuts, F. Uytdehaag, and A. Osterhaus. 1990. Rabies virus cross-reactive murine T cell clones: analysis of helper and delayed-type hypersensitivity function. Viral Immunol. 3:41.
32. + T Cells that are cytotoxic and display Th1-like cytokine secretion profile: heterogeneity in cytotoxic activity and cytokine secretion levels. Eur. J. Immunol. 23:2189.
33. Mills, K. H., A. Barnard, J. Watkins, and K. Redhead. 1993. Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model. Infect. Immun. 61:399.
34. + subset expression in murine candidiasis. Th responses correlate directly with genetically determined susceptibility or vaccine-induced resistance. J. Immunol. 150:925.
35. + T-cell clones: T helper type 1-like phenotype and reactivity with shed trypomastigote antigens. Infect. Immun. 61:3250.
36. + T cell subsets and induces early resistance to Leishmania major in mice. J. Exp. Med. 178:567.
37. + cytolytic T cell clone confers protection against murine malaria. J. Exp. Med. 172:1353.
38. Taylor Robinson, A. W., R. S. Phillips, A. Severn, S. Moncada, and F. Y. Liew. 1993. The role of Th1 and Th2 cells in a rodent malaria infection. Science 260: 1931.
39. Migliorini, P., B. Betschart, and G. Corradin. 1993. Malaria vaccine: immunization of mice with a synthetic T cell helper epitope alone leads to protective immunity. Eur. J. Immunol. 23:582.
40. Mougneau, E., F. Altare, A. E. Wakil, S. Zheng, T. Coppola, Z. Wang, R. Waldmann, R. M. Locksley, and N. Glaichenhaus. 1995. Expression cloning of a protective Leishmania antigen. Science 268:563.
41. + T lymphocytes. J. Immunol. 155:259.
42. Hoffman, S. L., E. D. Franke, W. O. Rogers, and S. Mellouk. 1993. Preerythrocytic malaria vaccine development. In Molecular Immunological Considerations in Malaria Vaccine Development. M. F. Good and A. J. Saul, eds. CRC Press, Boca Raton, FL, p. 149.